Huntington Disease
📧 Sign up to get email alerts when something new happens for Huntington Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users [Phase 1]
Pfizer conducted a Phase 1 study to evaluate the abuse potential of single oral doses of dimebon (latrepirdine) in healthy recreational poly…
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease [Phase 1]
A Phase 1 open-label study evaluating the effect of food on SEN0014196 in subjects with Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Citalopram to Enhance Cognition in HD [Phase 2]
A Phase 2 trial tested citalopram for cognitive enhancement in Huntington's disease; the study has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Neuroprotection by Cannabinoids in Huntington's Disease [Phase 2]
A Phase 2 Huntington's disease trial evaluating neuroprotection by cannabinoids has completed. The update does not include detailed results.
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: Creatine Safety & Tolerability in Huntington's Disease [Phase 2]
A Phase 2 trial evaluating the safety and tolerability of creatine in Huntington's disease has completed, with results posted in December 20…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Atomoxetine and Huntington's Disease [Phase 2]
Phase 2 trial evaluating atomoxetine for Huntington's disease with chorea; results were posted in 2012.
-
CLINICAL_TRIALS withdrawal · 2012-11-06Clinical Trial Update: Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon [NA]
The ramelteon trial for sleep/wake disturbances in basal ganglia disorders has been withdrawn, involving Huntington's disease and Parkinson'…
-
CLINICAL_TRIALS research · 2012-09-27Clinical Trial Update: Research of Biomarkers in Parkinson Disease
A completed clinical trial evaluating biomarkers in Parkinson disease and related parkinsonian conditions.
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease [Phase 1]
Phase 1 trial evaluating deep brain stimulation of the globus pallidus in Huntington's disease has completed.
-
FDA approval · 2012-08-17FDA Approved: XENAZINE — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Xenazine (tetrabenazine) by Lundbeck Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) [Phase 2]
Phase 2 safety and tolerability trial of phenylbutyrate in Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Cognitive Assessment Battery (CAB) Beta Study
This trial update reports that the Cognitive Assessment Battery (CAB) Beta Study for Huntington's disease has completed, sponsored by CHDI F…
-
CLINICAL_TRIALS research · 2012-03-27Clinical Trial Update: Memory Disorders Registry
The Memory Disorders Registry study is reported as completed, with conditions including dementia, Alzheimer's disease, Parkinson's disease, …
-
CLINICAL_TRIALS research · 2012-03-19Clinical Trial Update: Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
An update on a Huntington disease clinical trial coordinated with the European Huntington's Disease Network (EHDN).
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Riluzole in Huntington's Disease [Phase 3]
Sanofi-sponsored Phase 3 trial of riluzole for Huntington's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Escalating Dose Study in Healthy Volunteers With SEN0014196 [Phase 1]
Phase 1 escalating-dose study of SEN0014196 in healthy volunteers has completed; Huntington's disease is listed as the condition.
-
CLINICAL_TRIALS trial_result · 2011-09-23Clinical Trial Update: Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea [Phase 2]
A Phase 2 trial evaluating mavoglurant (AFQ056) for reducing chorea in Huntington's disease was terminated. The update notes the study's sta…
-
CLINICAL_TRIALS trial_result · 2011-08-22Clinical Trial Update: Effects of Music Therapy on Huntington's Disease [Phase 1]
Phase 1 clinical trial evaluating music therapy for Huntington's disease has completed.
-
FDA approval · 2011-07-06FDA Approved: XENAZINE — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Xenazine (tetrabenazine) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2011-05-04FDA Approved: XENAZINE — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Xenazine (tetrabenazine) submitted by Lundbeck Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2011-03-07Clinical Trial Update: Cooperative Huntington's Observational Research Trial
Update on the Cooperative Huntington's Observational Research Trial. The current status is UNKNOWN.
-
CLINICAL_TRIALS research · 2010-08-16Clinical Trial Update: Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
A completed clinical trial examining quantitative EEG biomarkers in Huntington's disease with posted results in 2010.
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin [Phase 1]
Phase 1 study evaluating systemic absorption of dimebon when applied as a skin solution in participants with Alzheimer's disease or Huntingt…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) [Phase 1]
Pfizer conducted a Phase 1 pharmacokinetic study in healthy volunteers to compare four modified-release formulations of dimebon (latrepirdin…
-
CLINICAL_TRIALS research · 2009-12-30Clinical Trial Update: A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function [Phase 1]
A Phase 1, non-randomized, open-label pharmacokinetics and safety study of Dimebon (latrepirdine) in subjects with severely impaired and nor…